Immunohistochemistry Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The global immunohistochemistry market was valued at $2,388.5 million in 2021 and is projected to reach $4,530.56 million by 2031, registering a CAGR of 6.5% from 2022 to 2031. Immunohistochemistry is a valuable technique that is used for the identification and visualization of tissue antigens in biological research and clinical diagnostics. In addition, Immunohistochemistry (IHC) is a diagnostic technique that is conducted in a laboratory. It involves performing special tests on your biopsy tissue sample to help diagnose the disease more precisely.

The key factors that drive the growth of the market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease and a rise in healthcare expenditure boosts the market growth. However, a dearth of skilled professionals restricts the market growth in the forecast period. Moreover, rise in technological advancements in IHC, increase in a number of product approvals and availability of reimbursements for IHC tests offer lucrative opportunities to the market player operating in the immunohistochemistry market.

The global Immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research applications, and forensics. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research, the application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.

By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global Immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and thermo Fischer Scientific, Inc
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global immunohistochemistry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments

By Product

Antibody
- Type
- Primary Antibodies
- Secondary Antibodies
Reagents
- Type
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Diluents
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Other
Kits
- Type
- IHC Kits for Animal Tissue
- IHC Kits for Human Tissue
Equipment
- Type
- Slide staining Systems
- Tissue Processing Systems
- Slide Scanners
- Others

By Application

Diagnosis
- Type
- Infectious diseases
- Neurological diseases
- Nephrological diseases
- Autoimmune diseases
- Cancer
- Others
Research Applications
- Type
- Drug Testing
- Others
Forensic

By End User

Hospital and Diagnostic Labs
Research Institutes and Academic Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Italy
- Spain
- Rest of Europe
- Germany
- France
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies Inc
- Abcam Plc
- F hoffman La Roche
- Merck Kgaa
- Biorad Laboratories
- Thermofischer Scientific Inc
- Cell Signaling Technology, Inc
- Bio SB
- Takara Bio, Inc
- PHC Holdings Corporation
- Miltenyi Biotec
- CANDOR Bioscience GmbH
- Sakura Finetek Japan Co., Ltd
- Eagle Biosciences, Inc.
- Biocare Medical, LLC
- Elabscience, Inc.
- Biogenex Laboratories

Product Code: A11199

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Antibody
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Antibody Immunohistochemistry Market by Type
4.3 Reagents
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Reagents Immunohistochemistry Market by Type
4.4 Kits
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.4.4 Kits Immunohistochemistry Market by Type
4.5 Equipment
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.5.4 Equipment Immunohistochemistry Market by Type

CHAPTER 5: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Diagnosis
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Diagnosis Immunohistochemistry Market by Type
5.3 Research Applications
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.3.4 Research Applications Immunohistochemistry Market by Type
5.4 Forensic
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: IMMUNOHISTOCHEMISTRY MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospital and Diagnostic Labs
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Research Institutes and Academic Institutes
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: IMMUNOHISTOCHEMISTRY MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest Of Asia Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Agilent Technologies Inc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Abcam Plc
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 F hoffman La Roche
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Merck Kgaa
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Biorad Laboratories
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Thermofischer Scientific Inc
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Cell Signaling Technology, Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Bio SB
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Takara Bio, Inc
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 PHC Holdings Corporation
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
9.11 Miltenyi Biotec
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
9.12 CANDOR Bioscience GmbH
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
9.13 Sakura Finetek Japan Co., Ltd
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
9.14 Eagle Biosciences, Inc.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
9.15 Biocare Medical, LLC
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
9.16 Elabscience, Inc.
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
9.17 Biogenex Laboratories
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments